DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Galeterone is an investigational drug.
There have been 4 clinical trials for Galeterone. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2015.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Pancreatic Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are Tokai Pharmaceuticals, Novus Therapeutics, Inc, and Educational & Scientific LLC.
There are one hundred and eighteen US patents protecting this investigational drug and one international patent.
Recent Clinical Trials for Galeterone
|1911GCCC: Galeterone or Galeterone With Gemcitabine for Patients With Metastatic Pancreatic Adenocarcinoma||University of Maryland, Baltimore||Phase 2|
|Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone||Educational & Scientific LLC||Phase 1|
|Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Galeterone||Tokai Pharmaceuticals||Phase 1|
Top disease conditions for Galeterone
Top clinical trial sponsors for Galeterone
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Galeterone||⤷ Sign up for a Free Trial||Substituted thiohydantoin derivatives as androgen receptor antagonists||Janssen Pharmaceutica NV (Beerse, BE)||⤷ Sign up for a Free Trial|
|Galeterone||⤷ Sign up for a Free Trial||Selective androgen receptor degrader (SARD) ligands and methods of use thereof||UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (Knoxville, TN) GTX, INC. (Memphis, TN)||⤷ Sign up for a Free Trial|
|Galeterone||⤷ Sign up for a Free Trial||Selective androgen receptor degrader (SARD) ligands and methods of use thereof||GTX, INC. (Memphis, TN)||⤷ Sign up for a Free Trial|
|Galeterone||⤷ Sign up for a Free Trial||Humanized anti-ACTH antibodies and use thereof||ALDER BIOPHARMACEUTICALS, INC. (Bothell, WA)||⤷ Sign up for a Free Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Galeterone||Argentina||AR107432||2036-01-11||⤷ Sign up for a Free Trial|
|Galeterone||Australia||AU2017207268||2036-01-11||⤷ Sign up for a Free Trial|
|Galeterone||Australia||AU2019203280||2036-01-11||⤷ Sign up for a Free Trial|
|Galeterone||Australia||AU2021201018||2036-01-11||⤷ Sign up for a Free Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|